The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMonks Inv Regulatory News (MNKS)

Share Price Information for Monks Inv (MNKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,160.00
Bid: 1,158.00
Ask: 1,164.00
Change: 8.00 (0.69%)
Spread: 6.00 (0.518%)
Open: 1,150.00
High: 1,164.00
Low: 1,140.00
Prev. Close: 1,152.00
MNKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

7 Sep 2023 15:01

RNS Number : 7646L
Monks Investment Trust PLC
07 September 2023
 

THE MONKS INVESTMENT TRUST PLC (MNKS)

Legal Entity Identifier: 213800MRI1JTUKG5AF64

Results of Annual General Meeting 

At the Annual General Meeting ('AGM') held on 7 September 2023 shareholders approved the following resolutions:

Ordinary Resolutions

1. To receive and adopt the Financial Statements of the Company for the year ended 30 April 2023 with the Reports of the Directors and of the Independent Auditor thereon.

2. To approve the Directors' Remuneration Policy.

3. To approve the Directors' Annual Report on Remuneration for the year ended 30 April 2023.

4. To declare a final dividend of 3.15p per ordinary share.

5. To re-elect Mr KS Sternberg as a Director.

6. To re-elect Mr JJ Tigue as a Director.

7. To re-elect Ms BJ Richards as a Director.

8. To re-elect Professor Sir Nigel Shadbolt as a Director.

9. To re-elect Ms CM Boyle as a Director.

10. To elect Dr D Chaya as a Director.

11. To reappoint Ernst & Young LLP as Independent Auditor of the Company to hold office until the conclusion of the next Annual General Meeting at which the Financial Statements are laid before the Company.

12. To authorise the Directors to determine the remuneration of the Independent Auditor.

13. That, in substitution for any existing authority but without prejudice to the exercise of any such authority prior to the date hereof, the Directors of the Company be and they are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the 'Act') to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company ('Securities') provided that such authority shall be limited to the allotment of shares and the grant of rights in respect of shares with an aggregate nominal value of up to £1,149,433.30 (representing 10% of the Company's total issued share capital as at 15 June 2023), such authority to expire at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, unless previously revoked, varied or extended by the Company in a general meeting, save that the Company may at any time prior to the expiry of this authority make an offer or enter into an agreement which would or might require Securities to be allotted or granted after the expiry of such authority and the Directors shall be entitled to allot or grant Securities in pursuance of such an offer or agreement as if such authority had not expired.

Special Resolutions

14. That, subject to the passing of resolution 13 above, and in substitution for any existing power but without prejudice to the exercise of any such power prior to the date hereof, the Directors of the Company be and they are hereby generally empowered, pursuant to sections 570 and 573 of the Companies Act 2006 (the 'Act') to allot equity securities (within the meaning of section 560(1) of the Act) for cash either pursuant to the authority given by resolution 13 above or by way of the sale of treasury shares wholly for cash as if section 561(1) of the Act did not apply to any such allotment or sale, provided that this power:

a) expires at the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

b) shall be limited to the allotment of equity securities or the sale of treasury shares up to an aggregate nominal value of £1,149,433.30, being approximately 10% of the nominal value of the issued share capital of the Company as at 15 June 2023.

15. That, in substitution for any existing authority, but without prejudice to the exercise of any such authority prior to the date hereof, the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with section 701 of the Companies Act 2006 (the 'Act'), to make market purchases (within the meaning of section 693(4) of the Act) of fully paid ordinary shares of 5p each in the capital of the Company ('Shares'), (either for retention as treasury shares for future reissue, resale, transfer or for cancellation) provided that:

a) the maximum aggregate number of Shares hereby authorised to be purchased is 34,460,011, or, if less, the number representing approximately 14.99% of the issued ordinary share capital of the Company as at the date of the passing of this resolution;

b) the minimum price (exclusive of expenses) which may be paid for each Share is 5p;

c) the maximum price (exclusive of expenses) which may be paid for a Share shall be not more than the higher of: (i) 5 per cent above the average closing price on the London Stock Exchange of a Share over the five business days immediately preceding the date of purchase; and (ii) the higher of the price of the last independent trade of, and the highest current independent bid for, a Share on the London Stock Exchange; and

d) unless previously varied, revoked or renewed by the Company in a general meeting, the authority hereby conferred shall expire at the conclusion of the Annual General Meeting of the Company to be held in respect of the year ending 30 April 2024, save that the Company may, prior to such expiry, enter into a contract to purchase Shares under such authority which will or may be executed wholly or partly after the expiration of such authority and may make a purchase of Shares pursuant to any such contract.

Resolutions 1 to 15 were passed on a poll. A breakdown of the votes registered is shown below:

Resolution

Votes for (including votes at the discretion of the Chairman)

%

Votes Against

%

Votes Withheld

Ordinary Resolutions

1

70,335,195

99.97

22,675

0.03

14,475

2

70,018,313

99.72

193,859

0.28

160,173

3

70,059,401

99.74

181,815

0.26

131,129

4

70,345,829

99.98

12,271

0.02

14,245

5

69,081,837

98.25

1,227,564

1.75

62,944

6

69,069,164

98.24

1,239,951

1.77

63,230

7

69,116,950

98.30

1,194,057

1.70

61,338

8

69,060,335

98.23

1,246,485

1.77

65,525

9

69,059,147

98.22

1,251,696

1.78

61,502

10

70,178,026

99.80

138,419

0.19

55,900

11

70,178,570

99.78

151,241

0.22

42,534

12

70,293,662

99.95

36,742

0.05

41,941

13

70,261,992

99.89

74,644

0.11

35,709

Special Resolutions

14

70,187,877

99.82

124,589

0.17

59,879

15

69,571,653

98.90

772,465

1.10

28,227

 

 

Baillie Gifford & Co Limited

Company Secretaries

7 September 2023 

 

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUPUBABUPWGWM
Date   Source Headline
3rd May 202412:43 pmRNSNet Asset Value(s)
2nd May 202411:05 amRNSNet Asset Value(s)
1st May 20243:50 pmRNSClosed Period Confirmation
1st May 20243:45 pmRNSTotal Voting Rights
1st May 20243:39 pmRNSNet Asset Value(s)
30th Apr 20245:04 pmRNSTransaction in Own Shares
30th Apr 202412:01 pmRNSNet Asset Value(s)
30th Apr 20249:26 amRNSDirector/PDMR Shareholding
29th Apr 20244:57 pmRNSTransaction in Own Shares
29th Apr 20241:39 pmRNSNet Asset Value(s)
26th Apr 20245:13 pmRNSTransaction in Own Shares
26th Apr 202411:47 amRNSNet Asset Value(s)
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
25th Apr 202411:48 amRNSNet Asset Value(s)
24th Apr 20244:58 pmRNSTransaction in Own Shares
24th Apr 20241:08 pmRNSNet Asset Value(s)
23rd Apr 202411:56 amRNSNet Asset Value(s)
22nd Apr 202412:14 pmRNSNet Asset Value(s)
19th Apr 20245:07 pmRNSTransaction in Own Shares
19th Apr 202412:53 pmRNSNet Asset Value(s)
18th Apr 20244:55 pmRNSTransaction in Own Shares
18th Apr 202411:40 amRNSNet Asset Value(s)
17th Apr 20244:57 pmRNSTransaction in Own Shares
17th Apr 202412:58 pmRNSNet Asset Value(s)
16th Apr 20244:02 pmRNSNet Asset Value(s)
15th Apr 202411:29 amRNSNet Asset Value(s)
12th Apr 202412:05 pmRNSNet Asset Value(s)
11th Apr 20245:02 pmRNSTransaction in Own Shares
11th Apr 202411:56 amRNSNet Asset Value(s)
10th Apr 202412:47 pmRNSNet Asset Value(s)
9th Apr 20244:59 pmRNSTransaction in Own Shares
9th Apr 202411:28 amRNSNet Asset Value(s)
8th Apr 202411:35 amRNSNet Asset Value(s)
5th Apr 202411:38 amRNSNet Asset Value(s)
4th Apr 202411:38 amRNSNet Asset Value(s)
3rd Apr 202411:23 amRNSNet Asset Value(s)
2nd Apr 20244:34 pmRNSNet Asset Value(s)
2nd Apr 20244:02 pmRNSNet Asset Value(s)
2nd Apr 20242:28 pmRNSTotal Voting Rights
2nd Apr 20241:44 pmRNSNet Asset Value(s)
28th Mar 20244:53 pmRNSTransaction in Own Shares
28th Mar 202412:31 pmRNSNet Asset Value(s)
27th Mar 202412:05 pmRNSNet Asset Value(s)
26th Mar 20244:53 pmRNSTransaction in Own Shares
26th Mar 202412:07 pmRNSNet Asset Value(s)
25th Mar 202412:32 pmRNSNet Asset Value(s)
22nd Mar 20244:52 pmRNSTransaction in Own Shares
22nd Mar 202412:09 pmRNSNet Asset Value(s)
21st Mar 202412:06 pmRNSNet Asset Value(s)
20th Mar 20245:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.